Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N Bruce, Munther Khamashta, Bernie Rubin, Angela Carroll, Mark Daniels, Roger Abramino Levy, Ronald van Vollenhoven, Murray B Urowitz
22 May 2024
Clinical trial outcomes for SLE: what we have and what we need Laurent Arnaud, Ioannis Parodis, Hervé Devilliers, Francois Chasset
15 February 2024
Interferon pathway in SLE: one key to unlocking the mystery of the disease Lars Rönnblom, Dag Leonard
19 January 2024
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease Scott R P McDonnell, Van Anh Nguyen, Noah M Walton, Carsten Merkwirth, Feng Hong, Deborah Berg, Elena Tomaselli Muensterman, Richard A Furie
7 March 2024
Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus Ting-Wei Lin, Yu-Tsan Lin, Ya-Chiao Hu, Hsin-Hui Yu, Bor-Luen Chiang
19 January 2024
Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132 Daniel J Burge, Victoria P Werth, Susan A Boackle, James Posada
7 February 2024
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures Aikaterini Thanou, Judith A James, Cristina Arriens, Teresa Aberle, Eliza Chakravarty, Joseph Rawdon, Stavros Stavrakis, Joan T Merrill, Anca Askanase
19 January 2024
Systemic lupus in the era of machine learning medicine Kevin Zhan, Katherine A Buhler, Irene Y Chen, Marvin J Fritzler, May Y Choi
4 March 2024
Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trial Jane Salmon, Daniel J Wallace, Violeta Rus, Addison Cox, Claire Dykas, Brooke Williams, Yunpeng Ding, Petter-Arnt Hals, Line Johnsen, Peter E Lipsky
14 July 2024
Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis Thunyatorn Wuttiputhanun, Nuanjanthip Naiyarakseree, Suwasin Udomkarnjananun, Wonngarm Kittanamongkolchai, Leelahavanichkul Asada, Pajaree Chariyavilaskul, Natavudh Townamchai, Yingyos Avihingsanon
17 January 2024
Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies Gabriel Figueroa-Parra, Michael S Putman, Cynthia S Crowson, Alí Duarte-García
10 January 2024
Changing paradigms in the treatment of systemic lupus erythematosus Antonis Fanouriakis, George Bertsias
19 January 2024
Multiple polygenic risk scores can improve the prediction of systemic lupus erythematosus in Taiwan Yu-Chia Chen, Ting-Yuan Liu, Hsing-Fang Lu, Chung-Ming Huang, Chi-Chou Liao, Fuu-Jen Tsai
9 May 2024
Effects of systemic lupus erythematosus on the brain: a systematic review of structural MRI findings and their relationships with cognitive dysfunction Diana Valdés Cabrera, Tala El Tal, Ibrahim Mohamed, Santiago Eduardo Arciniegas, Stephanie Fevrier, Justine Ledochowski, Andrea M Knight
17 August 2024
Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE Devyn Zaminski, Amit Saxena, Peter Izmirly, Jill P Buyon, H Michael Belmont
14 November 2023
First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study Viktoria Hermann, Anastas Batalov, Svetlana Smakotina, Pierre-Eric Juif, Peter Cornelisse
19 January 2024
Intercurrent infection as a risk factor for disease flares in patients with systemic lupus erythematosus Fatma el Hadiyen, Michel W P Tsang-A-Sjoe, Birgit I Lissenberg-Witte, Alexandre E Voskuyl, Irene E M Bultink
1 July 2024
Prevalence of coeliac disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis Adonis Sotoodeh, Madeleine Nguyen Hoang, Karin Hellgren, Anders Forss
13 February 2024
Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count Guillaume Germain, Karen Worley, Sean D MacKnight, Bernard Rubin, Christopher F Bell, François Laliberté, Ana Urosevic, Mei Sheng Duh, Andrew Concoff
3 April 2024
When is the right time to change therapy? An observational study of the time to response to immunosuppressive drugs in systemic lupus erythematosus Chiara Tani, Michele Maffi, Giancarlo Cascarano, Viola Signorini, Dina Zucchi, Marina Menchini, Chiara Stagnaro, Linda Carli, Elena Elefante, Francesco Ferro, Chiara Cardelli, Maria Laura Manca, Marta Mosca
23 July 2024
